跳至主要内容
临床试验/NL-OMON53264
NL-OMON53264招募中不适用

High Flow Nasal Oxygen For Hypercapnic, Acidotic Exacerbation Chronic Obstructive Pulmonary Disease. (HicaP) - HFNO in COPD

Franciscus Gasthuis & Vlietland0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Known chronic obstructive pulmonary disease
  • Acute hypercapnic exacerbation of this condition, defined as:
  • o PaCO2>45 mmHg or >6.0 kPa
  • o pH 7.25-7.34
  • Age >40 years

排除标准

  • - Metabolic (component of) acidosis, defined as a bicarbonate <20 mmol/L.
  • - Non-invasive respiratory support (either NIV or HFNO) already started, e.g.
  • by ambulance or on the ward.
  • Immediate need for intubation, based on clinical judgement of the attending
  • Impossibility to apply either one of the two interventions
  • Patient not expected to give immediate or delayed informed consent (e.g.
  • cognitive impairment, psychological or mental inabilities).
  • Established home-NIV or home CPAP, known indication for home-NIV or CPAP
  • (e.g. OSAS or obesitas hypoventilation syndrome).
  • Impeding death
  • Concurrent (respiratory) diseases that may influence treatment efficacy:
  • acute heart infarction, cardiogenic lung edema, massive pulmonary embolism
  • (intermediate-high risk or more). NB; pulmonary infections (viral and
  • bacterial) are a common cause of exacerbation and are no reason for exclusion.
  • Other acute diseases that preclude participation in the trial such as
  • hemodynamic instability (need for vasopressors), reduced consciousness with
  • need for intubation, severe intoxication
  • Tracheostomized patients
  • Participation in other interventional trials
  • Impossibility to admit the patient to the participating ICU or monitored ward
  • (e.g. medium care / high dependency unit, depending on local infrastructure).

研究者

相似试验